- Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R01)
(RFA-DA-18-008)
National Institute on Drug Abuse
Application Receipt Date(s): August 17, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. - Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R21)
(RFA-DA-18-009)
National Institute on Drug Abuse
Application Receipt Date(s): August 17, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. - Advancing our Understanding of the Brain Epitranscriptome (R01)
(PAR-17-153)
National Institute of Mental Health
Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. - Advancing Our Understanding of the Brain Epitranscriptome (R21)
(PAR-17-152)
National Institute of Mental Health
Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
· Extracellular Vesicles and Substance Use Disorders (R01)
(PAR-17-250)
National Institute on Drug Abuse
Application Receipt Date(s): August 15, 2017, January 16, 2018, August 15, 2018, January 15, 2019, August 15, 2019, January 15, 2020), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
· Extracellular Vesicles and Substance Use Disorders (R21)
(PAR-17-242)
National Institute on Drug Abuse
Application Receipt Date(s): August 15, 2017, January 16, 2018, August 15, 2018, January 15, 2019, August 15, 2019, January 15, 2020, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates
Adolescent Brain Cognitive Development Study Announces Fast Track Data Release
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309